Vicarious Surgical (RBOT) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
1 Feb, 2026Opening remarks and agenda
Meeting called to order at 2:00 P.M. Eastern Time as a live webcast to maximize stockholder participation.
Agenda link displayed, with opportunity for questions on four proposals as presented.
Board and executive committee updates
Board members and executive team introduced, including CEO, President, CTO, CFO, and Head of Legal.
Independent public accounting firm and outside legal counsel present; Inspector of Election identified.
Shareholder proposals
Four proposals presented: election of seven directors, amendment to 2021 Equity Incentive Plan, amendment to Certificate of Incorporation for a reverse stock split, and ratification of Deloitte & Touche LLP as auditor.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Vicarious Surgical
- Stockholders will vote on dissolving the company, with distributions to them considered unlikely.RBOT
Proxy filing - Stockholders will vote on dissolving the company, with distributions to them considered unlikely.RBOTProxy filing
- Net loss narrowed to $7.3M in Q1 2026, but cash only funds operations through Q2 2026.RBOTQ1 2026
- Vote on a reverse stock split to support Nasdaq listing and investor access, with Board discretion.RBOTProxy filing
- Vote sought on a reverse stock split to support Nasdaq listing and broaden investor appeal.RBOTProxy Filing
- Net loss and expenses declined in 2025, with 2026 cash burn expected to decrease further.RBOTQ4 2025
- Robotic system targets untapped surgical markets with advanced intra-abdominal access and dexterity.RBOTH.C. Wainwright 27th Annual Global Investment Conference
- Operating expenses dropped 17% in Q3 and net loss narrowed as clinical milestones approach.RBOTQ3 2024
- Q2 2024 saw improved losses, $73.2M liquidity, and V1.0 system on track for fall integration.RBOTQ2 2024